GSA CAPITAL PARTNERS LLP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$595
-25.3%
11,845
-34.8%
0.05%
-48.5%
Q4 2022$796
-99.8%
18,168
+270.2%
0.10%
+94.1%
Q3 2021$505,000
-45.1%
4,908
-53.1%
0.05%
-51.0%
Q2 2021$920,000
+64.9%
10,463
+110.4%
0.10%
+14.3%
Q4 2020$558,000
+76.6%
4,973
+15.6%
0.09%
+111.6%
Q3 2019$316,0004,3010.04%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders